Logger Script
바로가기 및 건너띄기 링크
본문 바로가기
주메뉴 바로가기


논문 주제별검색 기관별검색

소적정원산(消積正元散) 및 옻나무 추출물 투여로 체중증가 및 일반활동도의 개선을 보인 진행성 위암환자 1례

A Case of Advanced Gastric Cancer Patient Treated with Sojeukjungwon-san and Allergen Removed Rhus Verniciflua Stokes(aRVS)

안지혜 (경희대학교 동서신의학병원) ,   정의민 ( 경희대학교 동서신의학병원) ,   정종수 ( 경희대학교 동서신의학병원) ,   박재우 ( 경희대학교 한의과대학) ,   윤성우 ( 경희대학교 동서신의학병원)

소적정원산(消積正元散) 및 옻나무 추출물 투여로 체중증가 및 일반활동도의 개선을 보인 진행성 위암환자 1례 - 저널명, 기관명, ISSN, 발행일, 권호, 페이지, 조회수, ISBN 정보 안내
저널명 大韓癌韓醫學會誌  기관명 大韓癌韓醫學會 
ISSN 1229-2621  발행일 2009-12-28 
권호 제 14권 제 1호  페이지 21-27 
조회수 645  ISBN  

초록

한글초록

한글 초록 없음

영어초록

Advanced gastric cancer is the most common type of all cancers in Korea, which account for approximately 18.1% of all incident cancers, and mortality from advanved gastric cancer is estimated at nearly 15.6% of death that caused by all cancer. In the conventional medicine, treatments of advanced gastric cancer include chemotherapy such like FOLFOX.
In this case report, we introduce a case of advanced gastric cancer with greater omentum, thyroid, supraclavicular lymph node metastasis who had received chemotherapy. Chemotherapy was stopped because of weight loss and neurologic symptom such like cognitive disorder. The patient visited M·μ Integrative cancer center in 2008, and was treated by Sojeukjungwon-san and allergen removed Rhus verniciflua stokes(aRVS). There was no evidence of brain metastasis. The patient showed improvement of cognitive disorder and gained weight.
Futher case study will be needed in order to determine the effects of Sojeukjungwon-san and allergen removed Rhus verniciflua stokes(aRVS) for the quality of life of advanced gastric cancer patients after chemotherapy.

열기 접기

참고문헌

이 논문의 참고문헌이 19 건이 있습니다.

1. 통계청, 사망원인통계: 시도/사망원인(103항목)/성별 연령표준화 사망률(2000~), 통계청
2. Soqa J, Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases, Cancer (2005-04-15), Vol 103-8, 1587-1595 ref
3. Hundahl SA, et al., The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis, Cancer (2000-02-15), Vol 88-4, 921-932 ref
4. R Labianca, E Berardi, F Malugani, Challenges in the treatment of gastrointestinal tumours, Annals of Oncology (2006), Vol 17(Supplement 5), v137-v141
5. 최빈혜, 허진일, 조동희 외 5 명, 消積正元散으로 호전된 積證환자 1례보고, 대한한방내과학회지 (2005), Vol 26-2, 482-488oasis
6. Kim JH, Kin HP, Jung CH, et al., Inhibition of cell cycle progression via p27Kip1 upregulation and apoptosis induction by an ethanol extract of Rhus verniciflua Stokes in AGS gastric cancer cells, Int Journal Mol Med (2006-07), Vol 18-1, 201-208
7. John C, Lauke DO, et al., Gastric cancer: diagnosis and treatment options, Am Fam physician (2004-03), Vol 69-5, 1133-1140
8. Ajani JA, Recent Developments in Cytotoxic Therapy for Advanced Gastric or Gastroesophageal Carcinoma: The Phase Ⅲ Trials, Gastrointest Cancer Res (2000-03), Vol 1(2 Supp1), 16-21
9. SS Wohrer, M Raderer, M Hejna, Palliative chemotherapy for advanced gastric cancer, Annals of Oncoloay (2004), Vol 15, 1585-1595 ref
10. 송홍석, 진행성 위암 환자에서 항암 화학요법의 역할, 대한내과학회지 (2006), Vol 71-3
11. Roth AD, Maibach R, Fazio N, et al., 5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase Ⅰ-Ⅱ trial, Ann Oncol (2004-05), Vol 15-5, 759-764 ref
12. C Louvet, T Andre, JM Tigaud, et al., Phase Ⅱ Study of Oxaliplatin, Fluorouracil, and Folinic Acid in Locally Advanced or Metastatic Gastric Cancer Patients, Journal of Clinical Oncology (2002-12), Vol 20-23, 4543-4548 ref
13. 지성배, 한재현, 허훈 외 7 명, 진행성 위암 환자에서의 FOLFOX6 항암치료, Journal Korean gastric cancer Assoc (2008), Vol 8-1, 40-46 ref
14. Cassidy J, Misset JL, Oxaliplatin-related side effects: characteristics and management, Semin Oncol (2002-10), Vol 29(5 Suppl 15), 11-20
15. Sioka C, Kyritsis AP, Central and peripheral nervous system toxicity of common chemotherapeutic agents, Cancer Chemother Pharmacol (2009-04), Vol 63-5, 761-767 ref
16. Ruolan Han, Yin M Yang, Joerg Dietrich, et al., Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system, Journal Biol (2009), Vol 7-4, 12
17. 김흥대, 대장암의 보조 항암요법, Korean Journal of clinical oncology (2008), Vol 4-2, 42-47 ref
18. 심범상, 최승훈, 위암에서의 변증분형에 관한 문헌적 고찰, 동의병리학회지 (1993), Vol 8, 295-303oasis
19. 김동희, 김성훈, 항암제 부작용에 대한 한방요법, 대전대학교 한의학연구소 논문집 (1993), Vol 2-1, 33-51oasis

열기 접기